Cite
HARVARD Citation
Silva, N. et al. (n.d.). Effectiveness and tolerability of tyrosine kinase inhibitors as treatment for advanced non-small cell carcinoma (NSCLC) in the elderly: a real-world practice three-centre experience. Lung cancer. pp. S57-S58. [Online].